BRD4 can be specifically inhibited to suppress growth and trigger apoptosis in a variety of cancerous cells, such as diffuse large B-cell lymphoma, breast and prostate cancer, and acute myeloid leukemia. This evidence concerns the gene BRD4 and prostate carcinoma.